C. Mark Schneyer

Affiliations

  • Evp, Chief Financial Officer at Acadia Pharmaceuticals Inc (ACAD), 2024-08-20
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ACAD $15.28 9,733 43,735 2024-08-19 Filing
ACAD $14.79 975 34,564 2024-06-10 Filing
ACAD $16.94 3,503 32,053 2024-05-02 Filing
ACAD $17.87 2,716 28,742 2024-04-08 Filing
ACAD $17.90 5,434 26,183 2024-03-27 Filing